Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback Medical Dialogues Bureau14 April 2020 3:16 PM ISTDelhi: Indian Pharma industry is producing enough stocks of essential medicines particularly HCQ to meet both domestic demands and to meet export...
Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production Medical Dialogues Bureau14 April 2020 2:52 PM ISTThe raw materials which earlier used to cost Rs 9,000 per kilogram are now being sold at Rs 55,000-75,000
Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD Medical Dialogues Bureau14 April 2020 1:45 PM ISTMumbai: The Joint Managing Director of Ipca Laboratories Ajit Kumar Jain on Saturday said that hydroxychloroquine is not approved as an anti-malarial...
Top priority on Delivery of Medicines through Speed Post: Minister Medical Dialogues Bureau14 April 2020 1:40 PM ISTDelhi: With the rising cases of coronavirus and the consequent lockdown preventing the movement of people even to take their essential...
Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance Medical Dialogues Bureau13 April 2020 3:48 PM ISTCompanies like Zydus Cadila and IPCA are the major manufacturers of hydroxychloroquine in the country, Jain said
Lupin Contributes Rs 21 crores in battle against COVID-19 Medical Dialogues Bureau13 April 2020 1:00 PM ISTMumbai: Lupin Limited has announced a contribution of INR 21 crores for relief efforts directed towards mitigating the COVID-19 crisis. Lupin's...
KKR's Envision Healthcare hires bank to explore debt restructuring: Report Medical Dialogues Bureau13 April 2020 9:00 AM ISTUS: Envision Healthcare Corp, a U.S. provider of physicians and other medical staff owned by buyout firm KKR & Co Inc (KKR.N), has hired a...
Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment Medical Dialogues Bureau12 April 2020 1:54 PM ISTNew York: U.S. drugmaker Pfizer Inc said on Thursday that early data has helped it identify a drug candidate with the potential to help treat patients...
Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection Medical Dialogues Bureau12 April 2020 1:30 PM ISTVazegepant is currently advancing to Phase 3 development for the acute treatment of migraines in adults under the Division of Neurology, having...
GSK , Vir Biotechnology enter collaboration to find coronavirus solutions Medical Dialogues Bureau12 April 2020 10:45 AM ISTLondon, UK and San Francisco, US: GlaxoSmithKline plc and Vir Biotechnology, Inc. have announced that they have signed a binding agreement to enter...
India should become self-reliant in medical equipment, devices: Kasturirangan Medical Dialogues Bureau12 April 2020 9:00 AM ISTBengaluru: India needs to come out with a policy to make the country self-reliant in the field of medical equipment and devices drawing lessons from...
Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries Medical Dialogues Bureau11 April 2020 9:30 AM ISTParis: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could...
